Identify the main points of agreed procedures for handling complaints

Sacrament of Reconciliation 1. Our parishes and communities must be a place of welcome, where each person is respected and loved, and in which everyone receives and shares their unique gifts.

How are the medicinal products identified to be part of an Article 31 non-pharmacovigilance referral? The Agency, with input from the competent authorities of the Member States MSs within the European Economic Area EEA as necessary, will identify the authorised medicinal products or the applicants concerned by the procedure.

Whenever possible, all authorised medicinal products concerned are identified using information from the Article 57 database.

If after consultation with the MSs it is concluded that the issue also concerns other medicinal product s e. From a procedural view point, only those medicinal products identified at the start of the procedure will be covered by its scope. However, to the extent that other medicinal products affected by the concern that triggers the Article 31 referral but not identified at start of procedure are authorised in the EEA, or subject to future authorisations by the MSs, the concerned MSs should take due consideration of the scientific conclusions of the procedure and apply them to these products.

What happens if the medicinal product involved is only authorised in one Member State? If it is concluded that the scope of the procedure concerns medicinal product s authorised in only one MS and the interest of the EU is not involved, an Article 31 non-pharmacovigilance referral procedure will not be initiated and the concern will be handled by the MS concerned.

When and how will an Article 31 non-pharmacovigilance referral be announced? The start of the procedure will be announced as part of the CHMP meeting highlightswhich will be published on the next working day following the CHMP meeting during which the matter is considered.

This communication will be provided for information only. The regulatory contact point identified by the marketing authorisation holder MAH in the Eudravigilance registration system will, by default, be the contact person and will receive all correspondence from the Agency regarding the Article 31 non-pharmacovigilance procedure.

In cases where the concerned products or applications cannot be identified using information in the Article 57 database, the Agency will liaise with the National Competent Authorities to identify the concerned products and corresponding contact person.

All documentation concerning the Article 31 non-pharmacovigilance referral will be sent only to the contact person as discussed above.

What happens if centrally authorised products are involved in the procedure?1 Please refer to the Questions & Answers on Article 20 Pharmacovigilance procedures..

6. How the product(s) are identified to be part of an Article 31 pharmacovigilance referral? Rev. March The Agency and competent authorities of the Member States (MSs) within the European Economic Area (EEA) will identify the authorised products that .

Residential care and nursing home standards and how to complain Residential care and nursing homes are overseen by the Regulation and Quality Improvement Authority (RQIA) which is responsible for monitoring the standards of private, voluntary and Trust homes.

The main points of the verbal comment/complaint should be recorded on the Verbal Record Form. (Appendix 3) If possible the staff member receiving the complaint should have a written record of the main points agreed by the complainant.

Procedure for handling School Complaints Children and Young People Services. 2 public, such as reception or the main entrance; the school website.

5 An effective procedure will identify areas of agreement between the parties. It. Introduction to duty of care in health and social care settings. Understand the implications of duty of care Define the Term 'Duty of Care'.

What you need to know

Standard 8: Health and Safety in an adult social care ion: Please list any two sets of legislation that you are aware of which relates to health and safety in your work setting/situation. Answer: 1. 2. health and safety in the work Understand the main points of care tasks agreed .